{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:05:19Z","timestamp":1785351919141,"version":"3.55.0"},"reference-count":164,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971054, 82273533, 81874238"],"award-info":[{"award-number":["31971054, 82273533, 81874238"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX1063"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX1063"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Psoriasis is a chronic inflammatory skin disease with a prevalence of 0.14% to 1.99%. The underlying pathology is mainly driven by the abnormal immune responses including activation of Th1, Th17, Th22 cells and secretion of cytokines. Patients with psoriasis are more likely to develop cardiovascular disease (CVD) which has been well recognized as a comorbidity of psoriasis. As mediators of hemostasis and thromboinflammation, platelets play an important part in CVD. However, less is known about their pathophysiological contribution to psoriasis and psoriasis-associated CVD. A comprehensive understanding of the role of platelet activation in psoriasis might pave the path for more accurate prediction of cardiovascular (CV) risk and provide new strategies for psoriasis management, which alleviates the increased CV burden associated with psoriasis. Here we review the available evidence about the biomarkers and mechanisms of platelet activation in psoriasis and the role of platelet activation in intriguing the common comorbidity, CVD. We further discussed the implications and efficacy of antiplatelet therapies in the treatment of psoriasis and prevention of psoriasis-associated CVD.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1238647","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T03:08:09Z","timestamp":1692241689000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Platelet activation: a promoter for psoriasis and its comorbidity, cardiovascular disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Ziqi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoran","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"B2","unstructured":"Global Report on Psoriasis2016"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"B6","article-title":"Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine","volume":"33","author":"Alwan","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular risk in patients with psoriasis: JACC review topic of the week","volume":"77","author":"Garshick","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.149","article-title":"Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis","volume":"133","author":"Samarasekera","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jaad.2010.01.050","article-title":"Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan","volume":"64","author":"Lin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09941.x","article-title":"Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U","volume":"163","author":"Abuabara","year":"2010","journal-title":"K Br J Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.03.009","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: A report of the American College of Cardiology\/American heart association task force on clinical practice guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0110-0","article-title":"Platelet biology and functions: new concepts and clinical perspectives","volume":"16","author":"van der Meijden","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01453","article-title":"Platelets in skin autoimmune diseases","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000505536","article-title":"Platelet dysfunction and its role in the pathogenesis of psoriasis","volume":"237","author":"Fan","year":"2021","journal-title":"Dermatology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee, heart disease and stroke statistics-2019 update: a report from the American heart association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2017.07.003","article-title":"Platelet oxidative stress as a novel target of cardiovascular risk in frail older people","author":"Fuentes","year":"2017","journal-title":"Vascul Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1038\/s41598-023-30103-2","article-title":"Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_630_20","article-title":"Hemostatic and Coagulation Profile in Psoriasis: A Hospital-Based case control study","volume":"67","author":"Mir","year":"2022","journal-title":"Indian J Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/01.EWX.0000532719.31339.7c","article-title":"Mean platelet volume: an immanent predictor of subclinical atherosclerosis in psoriatic patients compared with interleukin-1\u03b1 and interleukin-6","volume":"15","author":"Farag","year":"2018","journal-title":"Egypt Women Dermatol Soc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/ejdv.ejdv_36_17","article-title":"The relationship between platelet volume and risk of atherosclerosis in patients with psoriasis","volume":"38","author":"Mahrous","year":"2018","journal-title":"Egypt J Dermatol Venerol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/31172.10639","article-title":"A correlative study between platelet count, mean platelet volume and red cell distribution width with the disease severity index in psoriasis patients","volume":"11","author":"Raghavan","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.04.023","article-title":"Is enhanced platelet activation the missing link leading to increased cardiovascular risk in psoriasis","volume":"446","author":"Chandrashekar","year":"2015","journal-title":"Clin Chim Acta"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2015.56.3.712","article-title":"Mean platelet volume is elevated in patients with psoriasis vulgaris","volume":"56","author":"Kim","year":"2015","journal-title":"Yonsei Med J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2017.67076","article-title":"Association between mean platelet volume and disease severity in patients with psoriasis and psoriatic arthritis","volume":"34","author":"Kilic","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2017.71285","article-title":"Mean platelet volume and platelet distribution width levels in patients with mild psoriasis vulgaris with metabolic syndrome","volume":"35","author":"Korkmaz","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.14744\/SEMB.2018.69370","article-title":"Platelet count and mean platelet volume in psoriasis patients","volume":"54","author":"Ozkur","year":"2020","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5114\/amsad.2016.64444","article-title":"Platelet mass index is increased in psoriasis. A possible link between psoriasis and atherosclerosis","volume":"1","author":"Unal","year":"2016","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2014.2269","article-title":"Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis","volume":"24","author":"Capo","year":"2014","journal-title":"Eur J Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2020.02.008","article-title":"Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis","volume":"95","author":"Sirin","year":"2020","journal-title":"Bras Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.O-08-537","article-title":"Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4","volume":"57","author":"Tamagawa-Mineoka","year":"2008","journal-title":"Allergol Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/bjd.12285","article-title":"Platelet activation: a link between psoriasis per se and subclinical atherosclerosis\u2013a case-control study","volume":"169","author":"Saleh","year":"2013","journal-title":"Br J Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2010.01095.x","article-title":"Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis","volume":"19","author":"Garbaraviciene","year":"2010","journal-title":"Exp Dermatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9554.1000201","article-title":"Evaluation of soluble P-selectin and leptin serum levels in sera of patients of psoriasis and their possible role in the increase in the cardiovascular risks in psoriatic patients","volume":"5","author":"Fathy Agamia","year":"2014","journal-title":"J Clin Exp Dermatol Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2014.26.2.275","article-title":"Levels of serum soluble p-selectin and e-selectin in psoriatic patients","volume":"26","author":"Ataseven","year":"2014","journal-title":"Ann Dermatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.06.053","article-title":"Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin","volume":"62","author":"Tamagawa-Mineoka","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/147323001003800434","article-title":"Effect of narrow-band UVB phototherapy on soluble cell adhesion molecules in patients with psoriasis vulgaris","volume":"38","author":"Long","year":"2010","journal-title":"J Int Med Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"13043","DOI":"10.1038\/s41598-021-90684-8","article-title":"Psoriatic disease is associated with systemic inflammation, endothelial activation, and altered haemostatic function","volume":"11","author":"Visser","year":"2021","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2017.67077","article-title":"Long-term treatment of chronic plaque psoriasis with biological drugs can control platelet activation: targeting the bridge between inflammation and atherothrombosis","volume":"34","author":"Kwiek","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v8.i11.667","article-title":"Increased levels of circulating platelet-derived microparticles in psoriasis: Possible implications for the associated cardiovascular risk","volume":"8","author":"Papadavid","year":"2016","journal-title":"World J Cardiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3242143","article-title":"No significant reduction of circulating endothelial-derived and platelet-derived microparticles in patients with psoriasis successfully treated with anti-IL12\/23","volume":"2016","author":"Ho","year":"2016","journal-title":"BioMed Res Int"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e000507","DOI":"10.1161\/JAHA.113.000507","article-title":"Endothelial cell-, platelet-, and monocyte\/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors","volume":"3","author":"Takeshita","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12551","article-title":"Effects of anti-TNF-alpha agents on circulating endothelial-derived and platelet-derived microparticles in psoriasis","volume":"23","author":"Pelletier","year":"2014","journal-title":"Exp Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.314008","article-title":"Activated platelets induce endothelial cell inflammatory response in psoriasis via COX-1","volume":"40","author":"Garshick","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B46","article-title":"Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis","volume":"144","author":"Nickoloff","year":"1994","journal-title":"Am J Pathol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01268","article-title":"Thrombospondin-1\/CD47 interaction regulates Th17 and treg differentiation in psoriasis","volume":"10","author":"Rodr\u00edguez-Jim\u00e9nez","year":"2019","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-04-0280","article-title":"Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta-analysis","volume":"114","author":"Sansanayudh","year":"2015","journal-title":"Thromb Haemost"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.5603\/CJ.2013.0134","article-title":"Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention","volume":"20","author":"Rechcinski","year":"2013","journal-title":"Cardiol J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e19400","DOI":"10.1097\/MD.0000000000019400","article-title":"Elevated platelet distribution width predicts poor prognosis in hilar cholangiocarcinoma","volume":"99","author":"Li","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.225169","article-title":"Targeting P-selectin adhesion molecule in molecular imaging: P-selectin expression as a valuable imaging biomarker of inflammation in cardiovascular disease","volume":"60","author":"Perkins","year":"2019","journal-title":"J Nucl Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2003.08.021","article-title":"The adhesion molecule P-selectin and cardiovascular disease","volume":"24","author":"Blann","year":"2003","journal-title":"Eur Heart J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/ATVBAHA.120.314644","article-title":"Platelet extracellular vesicles: beyond the blood","volume":"41","author":"Puhm","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-017-6757-7","article-title":"The impact of vascular disease treatment on platelet-derived microvesicles","volume":"31","author":"Rosinska","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/09537100802082249","article-title":"Platelet function in cutaneous diseases","volume":"19","author":"Kasperska-Zajac","year":"2008","journal-title":"Platelets"},{"key":"B56","doi-asserted-by":"publisher","first-page":"154157","DOI":"10.1016\/j.cyto.2017.09.013","article-title":"Platelet-derived chemokines in inflammation and atherosclerosis","volume":"122","author":"Bakogiannis","year":"2019","journal-title":"Cytokine"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2009.11.023","article-title":"Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis","volume":"125","author":"Kowalska","year":"2010","journal-title":"Thromb Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.199505","article-title":"CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages","volume":"106","author":"Gleissner","year":"2010","journal-title":"Circ Res"},{"key":"B59","article-title":"Serum interferon-gamma is a psoriasis severity and prognostic marker","volume":"84","author":"Abdallah","year":"2009","journal-title":"Cutis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e27365","DOI":"10.1097\/MD.0000000000027365","article-title":"CXCL10 and its related key genes as potential biomarkers for psoriasis: Evidence from bioinformatics and real-time quantitative polymerase chain reaction","volume":"100","author":"Zou","year":"2021","journal-title":"Med (Baltimore)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12049","article-title":"STAT1 expression and activation is increased in lesional psoriatic skin","volume":"168","author":"Hald","year":"2013","journal-title":"Br J Dermatol"},{"key":"B62","article-title":"JAK\/STAT and VEGF\/PAK1 signaling as emerging targets for topical treatment of psoriasis: a pilot study","volume":"13","author":"Du","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666200311130133","article-title":"Decoding psoriasis: integrated bioinformatics approach to understand hub genes and involved pathways","volume":"26","author":"Choudhary","year":"2020","journal-title":"Curr Pharm Des"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1177299","article-title":"Exploration of the potential mechanism of the common differentially expressed genes in psoriasis and atopic dermatitis","volume":"2022","author":"Zhou","year":"2022","journal-title":"BioMed Res Int"},{"key":"B65","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.3390\/molecules26196086","article-title":"Cudraxanthone D ameliorates psoriasis-like skin inflammation in an imiquimod-induced mouse model via inhibiting the inflammatory signaling pathways","volume":"26","author":"Kim","year":"2021","journal-title":"Molecules"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1016\/j.jid.2022.02.018","article-title":"OAS1, OAS2, and OAS3 contribute to epidermal keratinocyte proliferation by regulating cell cycle and augmenting IFN-1-Induced jak1-Signal transducer and activator of transcription 1 phosphorylation in psoriasis","volume":"142","author":"Huang","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2014.0184","article-title":"Interferon-Beta, a decisive factor in angiogenesis and arteriogenesis","volume":"35","author":"Yildirim","year":"2015","journal-title":"J Interferon Cytokine Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-020-01382-6","article-title":"The role of interferon-gamma in cardiovascular disease: an update","volume":"69","author":"Elyasi","year":"2020","journal-title":"Inflammation Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-098392","article-title":"Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide\/cGMP signaling","volume":"111","author":"Isenberg","year":"2008","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-265561","article-title":"Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP\/protein kinase A signaling cascade","volume":"116","author":"Roberts","year":"2010","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2020.4507","article-title":"Role of thrombospondin\u22121 and thrombospondin\u22122 in cardiovascular diseases (Review)","volume":"45","author":"Zhang","year":"2020","journal-title":"Int J Mol Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.312246","article-title":"Inflammasome signaling and impaired vascular health in psoriasis","volume":"39","author":"Garshick","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.864185","article-title":"Endothelial dysfunction in psoriasis: an updated review","volume":"9","author":"Anyfanti","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100733","article-title":"Interplay between platelets and coagulation","volume":"46","author":"Sang","year":"2021","journal-title":"Blood Rev"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.04.080","article-title":"IL-17A increases ADP-induced platelet aggregation","volume":"408","author":"Maione","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.129635d","article-title":"Pathogenic role of IL-17 in endothelial dysfunction a link between rheumatoid arthritis and atherosclerosis","volume":"69","author":"Hot A","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/106.6.795","article-title":"Cytokine induction of platelet activation","volume":"106","author":"Lumadue","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530140720","article-title":"Cytokine-induced alteration of platelet and hemostatic function","author":"Burstein","year":"1996","journal-title":"Stem Cells"},{"key":"B79","doi-asserted-by":"publisher","first-page":"10900","DOI":"10.3390\/ijms231810900","article-title":"The controversial role of LPS in platelet activation in vitro","volume":"23","author":"Galgano","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051752","article-title":"Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis","volume":"8","author":"Singh","year":"2013","journal-title":"PloS One"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1673614","article-title":"IL-9 promotes the development of deep venous thrombosis by facilitating platelet function","volume":"118","author":"Feng","year":"2018","journal-title":"Thromb Haemost"},{"key":"B82","volume-title":"Biochemistry of platelet activating factor. 2023 apr 10. In: statPearls [Internet]","author":"Ashraf","year":"2023"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.jaci.2016.05.037","article-title":"Platelet-activating factor decreases skin keratinocyte tight junction barrier integrity","volume":"138","author":"Duan","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/all.12083","article-title":"Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation","volume":"68","author":"Krause","year":"2013","journal-title":"Allergy"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1883","article-title":"Platelet activating factor (PAF): A mediator of inflammation","volume":"48","author":"Upton","year":"2022","journal-title":"Biofactors"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/BF01966522","article-title":"Identification and quantitation of PAF from psoriatic scales","volume":"21","author":"Ramesha","year":"1987","journal-title":"Agents Actions"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb07943.x","article-title":"Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation","volume":"134","author":"Izaki","year":"1996","journal-title":"Br J Dermatol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01534593","article-title":"Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue","volume":"18","author":"Andersen","year":"1994","journal-title":"Inflammation"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12497850","article-title":"Role of the microcirculation in the treatment and pathogenesis of psoriasis","volume":"78","author":"Braverman","year":"1982","journal-title":"J Invest Dermatol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ajpath.2010.10.008","article-title":"Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-beta1 transgenic mice","volume":"178","author":"Singh","year":"2011","journal-title":"Am J Pathol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100694","article-title":"Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents","volume":"45","author":"Lordan","year":"2021","journal-title":"Blood Rev"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/nu10050604","article-title":"Inflammation, not cholesterol, is a cause of chronic disease","volume":"10","author":"Tsoupras","year":"2018","journal-title":"Nutrients"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2004.30","article-title":"Involvement of thromboxane A2 and tyrosine kinase in the synergistic interaction of platelet activating factor and calcium ionophore A23187 in human platelet aggregation","volume":"36","author":"Rasheed","year":"2004","journal-title":"Exp Mol Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.825892","article-title":"Platelets as key factors in inflammation: focus on CD40L\/CD40","volume":"13","author":"Cognasse","year":"2022","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002459","article-title":"Platelets guide leukocytes to their sites of extravasation","volume":"14","author":"Zuchtriegel","year":"2016","journal-title":"PloS Biol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1801366115","article-title":"Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction","volume":"115","author":"Popa","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-04-0336","article-title":"Mechanism and functional impact of CD40 ligand-induced von Willebrand factor release from endothelial cells","volume":"113","author":"Moller","year":"2015","journal-title":"Thromb Haemost"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.307074","article-title":"Platelet CD40 exacerbates atherosclerosis by transcellular activation of endothelial cells and leukocytes","volume":"36","author":"Gerdes","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000374105","article-title":"Soluble CD40 ligand promotes macrophage foam cell formation in the etiology of atherosclerosis","volume":"131","author":"Yuan","year":"2015","journal-title":"Cardiology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1251497","article-title":"Platelet aggregates-induced human CD34+ progenitor cell proliferation and differentiation to macrophages and foam cells is mediated by stromal cell derived factor 1 in vitro","volume":"36","author":"Stellos","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-462432","article-title":"Emerging roles for platelets as immune and inflammatory cells","volume":"123","author":"Morrell","year":"2014","journal-title":"Blood"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.22318.x","article-title":"Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules","volume":"122","author":"Ludwig","year":"2004","journal-title":"J Invest Dermatol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20012044","article-title":"A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J Exp Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1126\/science.1256478","article-title":"Neutrophils scan for activated platelets to initiate inflammation","volume":"346","author":"Sreeramkumar","year":"2014","journal-title":"Science"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01867","article-title":"Platelets aggregate with neutrophils and promote skin pathology in psoriasis","volume":"10","author":"Herster","year":"2019","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-08-0662","article-title":"Intravascular leukocyte migration through platelet thrombi: directing leukocytes to sites of vascular injury","volume":"113","author":"Ghasemzadeh","year":"2015","journal-title":"Thromb Haemost"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-01-0020","article-title":"Platelets regulate CD4(+) T-cell differentiation via multiple chemokines in humans","volume":"106","author":"Gerdes","year":"2011","journal-title":"Thromb Haemost"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.08.457","article-title":"High levels of platelet-lymphocyte complexes in patients with psoriasis are associated with a better response to anti-TNF-\u03b1 Therapy","volume":"140","author":"Sanz-Mart\u00ednez","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-030-11488-6_7","article-title":"Lipid metabolism and signaling in platelet function","volume":"1127","author":"Paes","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/s0923-1811(99)00042-0","article-title":"Psoriasis and the arachidonic acid cascade","volume":"21","author":"Ikai","year":"1999","journal-title":"J Dermatol Sci"},{"key":"B113","first-page":"7","article-title":"Determination of serum lipids, TXB2 6-ketoPGF1\u03b1, and platelet aggregation function in psoriatic patients","volume":"3","author":"Liu","year":"1986","journal-title":"Chin J Derm Venereol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-263509","article-title":"Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells","volume":"116","author":"Schirmer","year":"2010","journal-title":"Blood"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.05.036","article-title":"T cell-intrinsic prostaglandin E2-EP2\/EP4 signaling is critical in pathogenic TH17 cell-driven inflammation","volume":"143","author":"Lee","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jaci.2018.01.054","article-title":"Thromboxane A2 facilitates IL-17A production from V\u03b34+ \u03b3\u03b4 T cells and promotes psoriatic dermatitis in mice","volume":"142","author":"Ueharaguchi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"11873","DOI":"10.1038\/s41598-018-30373-1","article-title":"Resolvin E1 attenuates murine psoriatic dermatitis","volume":"8","author":"Sawada","year":"2018","journal-title":"Sci Rep"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1159\/000354119","article-title":"Cutaneous application of leukotriene b4 as an in vivo model of psoriasis-like skin inflammation: an immunohistological study","volume":"27","author":"Hendriks","year":"2014","journal-title":"Skin Pharmacol Physiol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12491695","article-title":"Cyclooxygenase activity is increased in platelets from psoriatic patients","volume":"97","author":"Vila","year":"1991","journal-title":"J Invest Dermatol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00508","article-title":"Neutrophil-derived cytokines: facts beyond expression","volume":"5","author":"Tecchio","year":"2014","journal-title":"Front Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.09.037","article-title":"Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis","volume":"68","author":"Ikeda","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacbts.2018.10.008","article-title":"Neutrophil subsets, platelets, and vascular disease in psoriasis","volume":"4","author":"Teague","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109274","article-title":"Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitis","volume":"249","author":"Michailidou","year":"2023","journal-title":"Clin Immunol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41598-020-80685-4","article-title":"Platelet CXCL4 mediates neutrophil extracellular traps formation in ANCA-associated vasculitis","volume":"11","author":"Matsumoto","year":"2021","journal-title":"Sci Rep"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-531582","article-title":"Platelets at the interface of thrombosis, inflammation, and cancer","volume":"126","author":"Franco","year":"2015","journal-title":"Blood"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018021758","article-title":"The endogenous antimicrobial cathelicidin LL37 induces platelet activation and augments thrombus formation","volume":"2","author":"Salamah","year":"2018","journal-title":"Blood Adv"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-018-03925-2","article-title":"Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation","volume":"9","author":"Pircher","year":"2018","journal-title":"Nat Commun"},{"key":"B128","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41467-019-13756-4","article-title":"Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis","volume":"11","author":"Herster","year":"2020","journal-title":"Nat Commun"},{"key":"B129","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.3390\/ijms22083850","article-title":"Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches","volume":"22","author":"Medina-Leyte","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31828a292c","article-title":"Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study","volume":"63","author":"O\u2019Brien","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.308126","article-title":"Activated platelets induce endothelial cell activation via an interleukin-1beta pathway in systemic lupus erythematosus","volume":"37","author":"Nhek","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2000.00061.x","article-title":"Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes","volume":"100","author":"Kotowicz","year":"2000","journal-title":"Immunology"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000092941.77774.3C","article-title":"Mechanisms of leukotriene B4\u2014triggered monocyte adhesion","volume":"23","author":"Friedrich","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-718114","article-title":"The role of leukocytes in thrombosis","volume":"128","author":"Swystun","year":"2016","journal-title":"Blood"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-413047","article-title":"Platelets can enhance vascular permeability","volume":"120","author":"Cloutier","year":"2012","journal-title":"Blood"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-020-01889-3","article-title":"Current and future therapies for psoriasis with a focus on serotonergic drugs","volume":"57","author":"Martins","year":"2020","journal-title":"Mol Neurobiol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e32832f6c5b","article-title":"The influence of low-dose aspirin and hydroxyurea on platelet-leukocyte interactions in patients with essential thrombocythemia","volume":"20","author":"Trelinski","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3A0415-161R","article-title":"Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets","volume":"99","author":"Carestia","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12101","article-title":"Platelets and autoimmunity","volume":"43","author":"Habets","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2022.10.010","article-title":"2022 Taiwanese Dermatological Association (TDA), Taiwanese Association for Psoriasis and Skin Immunology (TAPSI), and Taiwan Society of cardiology (TSOC) joint consensus recommendations for the management of psoriatic disease with attention to cardiovascular comorbidities","volume":"122","author":"Chi","year":"2023","journal-title":"J Formos Med Assoc"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6661847","article-title":"Effect of statins on platelet activation and function: from molecular pathways to clinical effects","volume":"2021","author":"Nenna","year":"2021","journal-title":"BioMed Res Int"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1177\/0300060516675681","article-title":"Effects of atorvastatin on ADP-, arachidonic acid-, collagen-, and epinephrine-induced platelet aggregation","volume":"45","author":"Zhao","year":"2017","journal-title":"J Int Med Res"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2013.01.007","article-title":"Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms","volume":"131","author":"Moscardo","year":"2013","journal-title":"Thromb Res"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2010.10.006","article-title":"Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia","volume":"214","author":"Puccetti","year":"2011","journal-title":"Atherosclerosis"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2013.09.006","article-title":"Antioxidant and antiplatelet effects of atorvastatin by Nox2 inhibition","volume":"24","author":"Violi","year":"2014","journal-title":"Trends Cardiovasc Med"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000153810.81187.7D","article-title":"Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients","volume":"111","author":"Sanguigni","year":"2005","journal-title":"Circulation"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.5603\/cj.2012.0005","article-title":"Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand","volume":"19","author":"Stach","year":"2012","journal-title":"Cardiol J"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres","article-title":"Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry","volume":"115","author":"Labi\u00f3s","year":"2005","journal-title":"Thromb Res"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/aphA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.900916","article-title":"Current evidence on the role of lipid lowering drugs in the treatment of psoriasis","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/aoms.2019.90343","article-title":"The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials","volume":"16","author":"Socha","year":"2020","journal-title":"Arch Med Sci"},{"key":"B153","doi-asserted-by":"publisher","first-page":"e14114","DOI":"10.1111\/ijcp.14114","article-title":"The effect of secukinumab treatment on inflammatory parameters in patients with psoriasis: A multicentre restrospective study","volume":"75","author":"An","year":"2021","journal-title":"Int J Clin Pract"},{"key":"B154","first-page":"4","article-title":"Effect of psoralen and ultraviolet A on platelet functioning: an in vitro and in vivo study","volume":"9","author":"Procaccini","year":"1992","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"B155","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2353\/ajpath.2006.060079","article-title":"Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis","volume":"169","author":"Wolf","year":"2006","journal-title":"Am J Pathol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.050","article-title":"The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor-\u03b1 inhibitors versus phototherapy: An observational cohort study","volume":"79","author":"Wu","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1111\/jphp","article-title":"Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels","volume":"70","author":"Bilia","year":"2018","journal-title":"J Pharm Pharmacol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/283634","article-title":"Oral curcumin (Meriva) is effective as an adjuvant treatment and is able to reduce IL-22 serum levels in patients with psoriasis vulgaris","volume":"2015","author":"Antiga","year":"2015","journal-title":"BioMed Res Int"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10123180","article-title":"Regulatory effects of curcumin on platelets: an update and future directions","volume":"10","author":"Hussain","year":"2022","journal-title":"Biomedicines"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109032","article-title":"The immunoregulatory effects of natural products on psoriasis via its action on Th17 cells versus regulatory T cells balance","volume":"110","author":"Zhong","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2010.09.017","article-title":"Antithrombotic effect of grape seed proanthocyanidins extract in a rat model of deep vein thrombosis","volume":"53","author":"Zhang","year":"2011","journal-title":"J Vasc Surg"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.105858","article-title":"Thymol-enriched extract from Thymus vulgaris L leaves: Green extraction processes and antiaggregant effects on human platelets","volume":"125","author":"Adhar","year":"2022","journal-title":"Bioorg Chem"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2015.06.001","article-title":"Kaempferol inhibits thrombosis and platelet activation","volume":"115","author":"Choi","year":"2015","journal-title":"Biochimie"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3634","article-title":"Inhibitory effects of luteolin\u22124\u2019\u2212O\u2212\u03b2\u2212D\u2212glucopyranoside on P2Y12 and thromboxane A2 receptor\u2212mediated amplification of platelet activation in vitro","volume":"42","author":"Xu","year":"2018","journal-title":"Int J Mol Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1238647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T03:08:17Z","timestamp":1692241697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1238647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":164,"alternative-id":["10.3389\/fimmu.2023.1238647"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1238647","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"article-number":"1238647"}}